These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38017512)

  • 1. In silico prediction of bioequivalence of atorvastatin tablets based on GastroPlus™ software.
    Wang L; Chen J; Chen W; Ruan Z; Lou H; Yang D; Jiang B
    BMC Pharmacol Toxicol; 2023 Nov; 24(1):69. PubMed ID: 38017512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of plasma concentrations using in silico modelling and simulation approach: Case of Acebutolol.
    Bokri E; Felfel H; Bahri S
    Ann Pharm Fr; 2021 Sep; 79(5):530-538. PubMed ID: 33675740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the bioequivalence of metronidazole tablets and analyzing the effect of
    Zhang S; Fang M; Zhang Q; Li X; Zhang T
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1646-1653. PubMed ID: 31342807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting bioequivalence and developing dissolution bioequivalence safe space in vitro for warfarin using a Physiologically-Based pharmacokinetic absorption model.
    Cheng ZZ; Hu X; Li YL; Zhang L
    Eur J Pharm Biopharm; 2023 Oct; 191():12-25. PubMed ID: 37567396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically Based Biopharmaceutics Modeling to Demonstrate Virtual Bioequivalence and Bioequivalence Safe-space for Ribociclib which has Permeation Rate-controlled Absorption.
    Laisney M; Heimbach T; Mueller-Zsigmondy M; Blumenstein L; Costa R; Ji Y
    J Pharm Sci; 2022 Jan; 111(1):274-284. PubMed ID: 34678270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo correlation of efavirenz tablets using GastroPlus®.
    Honório Tda S; Pinto EC; Rocha HV; Esteves VS; dos Santos TC; Castro HC; Rodrigues CR; de Sousa VP; Cabral LM
    AAPS PharmSciTech; 2013 Sep; 14(3):1244-54. PubMed ID: 23943401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability.
    Dennison TJ; Smith JC; Badhan RK; Mohammed AR
    Drug Des Devel Ther; 2017; 11():811-826. PubMed ID: 28352156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.
    Liu YM; Pu HH; Liu GY; Jia JY; Weng LP; Xu RJ; Li GX; Wang W; Zhang MQ; Lu C; Yu C
    Clin Ther; 2010 Jul; 32(7):1396-407. PubMed ID: 20678686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of bioequivalence of Isosorbide Mononitrate tablets with different dissolution profiles using PBPK modeling and simulation.
    Zhang F; Zhou Y; Wu N; Jia R; Liu A; Liu B; Zhou Z; Hu H; Han Z; Ye X; Ding Y; He Q; Wang H
    Eur J Pharm Sci; 2021 Feb; 157():105618. PubMed ID: 33122011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen.
    Tsume Y; Langguth P; Garcia-Arieta A; Amidon GL
    Biopharm Drug Dispos; 2012 Oct; 33(7):366-77. PubMed ID: 22815122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro In Vivo Extrapolation and Bioequivalence Prediction for Immediate-Release Capsules of Cefadroxil Based on a Physiologically-Based Pharmacokinetic ACAT Model.
    Rahim N; Naqvi SBS
    AAPS PharmSciTech; 2024 May; 25(5):100. PubMed ID: 38714602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Prediction of Plasma Concentrations of Fluconazole Capsules with Different Dissolution Profiles and Bioequivalence Study Using Population Simulation.
    Duque MD; Silva DA; Issa MG; Porta V; Löbenberg R; Ferraz HG
    Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31060289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based absorption modeling to predict the bioequivalence of two cilostazol formulations.
    Wang L; Zhao P; Luo T; Yang D; Jiang Q; Chen J; Lou H; Ruan Z; Jiang B
    Clin Transl Sci; 2023 Nov; 16(11):2323-2330. PubMed ID: 37718502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of atorvastatin in Chinese subjects
.
    Xu SM; Yan J; Li D; Li D; Li XM; Xu PS
    Int J Clin Pharmacol Ther; 2020 Feb; 58(2):112-120. PubMed ID: 31829925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of in vitro biorelevant dissolution and in silico PBPK model of carvedilol to predict bioequivalence of oral drug products.
    Ibarra M; Valiante C; Sopeña P; Schiavo A; Lorier M; Vázquez M; Fagiolino P
    Eur J Pharm Sci; 2018 Jun; 118():176-182. PubMed ID: 29605455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A physiologically-based drug absorption modeling for orally disintegrating tablets.
    Kambayashi A; Kiyota T
    Eur J Pharm Biopharm; 2020 Jul; 152():1-9. PubMed ID: 32371153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection.
    Gajewska M; Blumenstein L; Kourentas A; Mueller-Zsigmondy M; Lorenzo S; Sinn A; Velinova M; Heimbach T
    AAPS J; 2020 Oct; 22(6):134. PubMed ID: 33070288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis - a case study for a BCS class II drug.
    Danielak D; Paszkowska J; Staniszewska M; Garbacz G; Terlecka A; Kubiak B; Romański M
    Eur J Pharm Biopharm; 2023 May; 186():132-143. PubMed ID: 37015321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing the Safe Space via Physiologically Based Biopharmaceutics Modeling. Case Study: Fevipiprant/QAW039.
    Kourentas A; Gajewska M; Lin W; Dhareshwar SS; Steib-Lauer C; Kulkarni S; Hirsch S; Heimbach T; Mueller-Zsigmondy M
    AAPS J; 2023 Feb; 25(1):25. PubMed ID: 36788163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.